Related Experiment Video
Updated: Mar 19, 2026

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
Published on: February 28, 2012
Evaluating real-world mortality risk after defibrillator implantation
Lisa W M Leung1, Zaki Akhtar2, Oswaldo Valencia3
1Consultant Cardiologist and Electrophysiologist.
Implantable cardioverter-defibrillators protect against sudden cardiac death. However, early death risk in candidates may be better predicted using biomarkers like red cell distribution width (RDW), alongside age and ejection fraction.
Area of Science:
- Cardiology
- Medical Devices
- Biomarkers
Background:
- Implantable cardioverter-defibrillators (ICDs) are crucial for preventing sudden cardiac death (SCD) from ventricular arrhythmias.
- Current guidelines often contraindicate ICD implantation for patients with less than one year life expectancy.
- Assessing prognosis in ICD candidates remains challenging, potentially leading to suboptimal device selection.
Purpose of the Study:
- To evaluate outcomes of ICD recipients, focusing on early mortality (<12 months post-implant).
- To identify predictors of early death in ICD recipients, particularly non-arrhythmic causes.
- To explore the utility of biomarkers, such as red cell distribution width (RDW), in refining prognostic assessment for ICD candidates.
Main Methods:
- Retrospective analysis of 235 patients who received transvenous ICDs in 2015 for primary or secondary SCD prevention.
- Data collection included patient demographics, device information, and mortality outcomes over a mean follow-up of 66.2 months.
- Statistical analysis, including univariate and multivariate analyses and Receiver Operator Characteristic (ROC) curve analysis, was used to identify mortality predictors.
Main Results:
- Out of 235 patients, 77 (32.8%) died during follow-up; 20 (8.5%) died within 12 months post-implant.
- None of the early deaths were directly attributed to arrhythmias.
- Significant predictors of mortality included older age, ejection fraction <35%, and elevated red cell distribution width (RDW >14.75%).
- RDW demonstrated strong association with early mortality risk (p<0.001) with good diagnostic performance (AUC 0.75).
Conclusions:
- Current prognostic assessments for ICD candidates have limitations.
- Red cell distribution width (RDW) is a significant predictor of early, non-arrhythmic death in ICD recipients.
- Integrating biomarkers like RDW into clinical frailty scores could improve pre-assessment and risk stratification for ICD candidates.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiopulmonary Resuscitation III: AED Use
Actuarial Approach
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Dysrhythmias V: Evaluating Dysrhythmias
Dysrhythmias VI: Management of Dysrhythmias

